Results 31 to 40 of about 10,145,629 (294)
Ketamine as Add-On Treatment in Psychotic Treatment-Resistant Depression
Psychotic treatment-resistant depression is a complex and challenging manifestation of mood disorders in the clinical setting. Psychotic depression is a subtype of major depressive disorder characterized by mood-consistent hallucinations and/or delusions.
Maria Gałuszko-Węgielnik +4 more
doaj +1 more source
Metacognitive Therapy in Treatment-Resistant Psychosis:A Multiple-Baseline Study [PDF]
Background: More effective psychological treatments for psychosis are required. Case series data and pilot trials suggest metacognitive therapy (MCT) is a promising treatment for anxiety and depression.
Wardle, Melissa +8 more
core +1 more source
Acute Onset of Suicidal Ideation after Starting Lemborexant in a Patient with a Mood Disorder
A 24-year-old woman with treatment-resistant depressive symptoms and chronic insomnia developed acute, intrusive suicidal ideation with intent on day 5 after starting lemborexant 10 mg nightly.
Renato Rodrigo Silva +3 more
doaj +1 more source
Antidepressant discontinuation in treatment resistant depression
Treatment-resistant depression (TRD) is a growing problem in psychiatric practice with some 15–20% of depressed patients becoming chronically depressed and perhaps as many as 40% in tertiary settings.
Ziad A. Ali +2 more
doaj +1 more source
Treatment-resistant depression in adolescents: is the addition of cognitive behavioral therapy of benefit? [PDF]
Sarah E Hetrick1, Georgina R Cox1, Sally N Merry21Orygen Youth Health Research Centre, Centre for Youth Mental Health, Melbourne, Parkville, Victoria, Australia; 2Werry Centre for Child and Adolescent Mental Health, Department of Psychological Medicine ...
Cox, GR +8 more
core +1 more source
Opioid agents for treatment-resistant depression
Treatment-resistant depression (TRD) is a major public health problem in terms of prevalence, individual suffering, and cost for society, and it is commonly associated with significant disability and psychosocial impairment worldwide.
Amerio A. +5 more
core +1 more source
Aim Approximately one‐third of patients with major depressive disorder develop treatment‐resistant depression. One‐third of patients with treatment‐resistant depression demonstrate resistance to ketamine, which is a novel antidepressant effective for ...
Tomoyuki Nakamura +7 more
doaj +1 more source
Neuromodulation for treatment-resistant depression [PDF]
Treatment-resistant depression affects at least 1-3% of the US population. This article reviews the current state of focal neuromodulation therapies for treatment-resistant depression, focusing on those treatments published clinical data. These include transcranial magnetic stimulation, transcranial direct current stimulation, magnetic seizure therapy,
Holtzheimer, Paul E., Mayberg, Helen S.
openaire +2 more sources
Heterodimeric amino acid transporters consist of SLC7 and SLC3 family proteins arranged in a conserved structural organization. They regulate nutrient transport across cell membranes, supporting essential cellular functions. These transporters also contribute to xenobiotic/drug uptake and distribution.
Mariafrancesca Scalise +5 more
wiley +1 more source
Treatment-resistant depression and its diagnosis and treatment
The aim of this study is to explore the diagnostic strategies and options for treatment-resistant depression (TRD). Despite the well-established efficacy of antidepressants, 20%~30% of depressive patients in the clinic fail to respond or respond poorly ...
Hu Shaohua
doaj +1 more source

